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Available online 14 November 2016Background: Symptomatic non-obstructive coronary artery disease is a growing clinical dilemma for which
contemporary testing is proving to be of limited clinical utility. New methods are needed to identify cardiac
dysfunction.
Methods and results: This is a prospective observational cohort study conducted from December 2013 to August
2015 in two outpatient cardiology clinics (symptomatic cohort) and 24 outpatient practices throughout the US
(healthy cohort) with centralized methodology andmonitoring to compare heart-rate responses during cardiopul-
monary exercise testing (CPET). Participants were 208 consecutive patients (median age, 61; range, 32–86 years)
with exercise intolerance and without prior heart or lung disease in whom coronary anatomy was deﬁned and
116 healthy subjects (median age, 45; range, 26–66 years). Compared to stress ECG, the novel change in heart-
rate as a function of work-rate parameter (ΔHR-WR Slope) demonstrated signiﬁcantly higher sensitivity to detect
under-treated atherosclerosis with similar speciﬁcity. In men, area under the ROC curve increased from 60% to
94% for non-obstructive CAD and from 64% to 80% for obstructive CAD. In women, AUC increased from 64% to
85% for non-obstructive CAD and from 66% to 90% for obstructive CAD. ΔHR-WR Slope correctly reclassiﬁed abnor-
mal studies in the non-obstructive CADgroup from22% to 81%; in the obstructive CADgroup from18% to 84% and in
the revascularization group from 35% to 78%.
Conclusion: Abnormal heart-rate response during CPET is more effective than stress ECG for identifying under-
treated atherosclerosis and may be of utility to identify cardiac dysfunction in symptomatic patients with normal
routine cardiac testing.
© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND li-
cense (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Women1. Introduction
Ischemic heart disease (IHD) caused by coronary atherosclerosis in-
volves multifactorial pathophysiological processes that alter the coronary
vasculature and result in endothelial dysfunction, increased microvascu-
lar resistance and to varying degrees of obstructive coronary artery
disease (O-CAD) [1]. Symptoms (angina) caused by non-obstructive cor-
onary artery disease (NO-CAD) are frequently atypical in nature (dys-
pnea, fatigue, nausea, and epigastric discomfort), challenging to discerneter Center West, Suite W-211,
.
land Ltd. This is an open access articlas being cardiac in origin and occur more frequently in women than
men [2]. Outcomes data has shown that symptomatic patients with NO-
CAD have similar morbidity and mortality as patients with O-CAD [3–7].
Despite a lack of signiﬁcant coronary obstruction, these patients often
have persistent symptoms, recurrent hospitalizations, decreased func-
tional status, increased adverse CV events and consume health care ser-
vices with repeat medical assessments and procedures [4,8–10]. Recent
data has shown that patients with angina and without O-CAD frequently
have microvascular ischemia conﬁrmed by functional coronary angio-
gram studies [11]. The contemporary stress imaging modalities (stress
echocardiography and nuclear myocardial perfusion imaging) that were
developed to increase sensitivity to detect O-CAD compared to stress
ECG are of limited value in detecting inducible microvascular ischemiae under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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still the recommended initial procedure for non-invasive evaluation of
women at intermediate risk for suspected IHD [16].
Accurate detection of inducible ischemia from NO-CAD is a growing
clinical dilemma for which current clinical tools are not adequate and
newmethodologies need to be developed. The ability for cardiopulmo-
nary exercise testing (CPET) to detect left-ventricular dysfunction
caused by inducible ischemia is recognized as a new application by
the American Heart Association [17]. CPET provides a physiologic quan-
tiﬁcation of the WR, HR, and oxygen uptake (VO2) at which myocardial
dysfunction develops [18]. The depletion of high energy phosphate
bonds past the ischemic threshold results in mechanical dysfunction
during exercise with subsequent decrease in stroke volume with in-
creasing work-rate. Since cardiac output to the working skeletal mus-
cles must increase with progressively increasing resistance, the
autonomic nervous system response is up-regulated at the ischemic
threshold and the HR response is accelerated from baseline as a com-
pensatorymechanism tomeet the body's increasing need for peripheral
perfusion. The ischemia may be diffuse and evenly distributed or re-
gional, from small or large vessel disease; the signiﬁcance of a height-
ened HR response is that a global cardiac problem exists. Mechanical
dysfunction may subsequently be followed by ECG changes and symp-
toms comprising the ischemic cascade [19]. In this regard, careful anal-
ysis of oxygen uptake kinetics has been shown to be superior to
traditional stress ECG for the diagnosis of O-CAD in two studies
assessing patients with chest pain [20,21]. Greater clarity is needed to
deﬁne the role of CPET in the evaluation of IHD. The purpose of this
study is to quantitate differences in HR response patterns in a cohort
of healthy subjects with a cohort of symptomatic patients assessed by
CPET using coronary angiogram as the gold standard to quantify the de-
gree of large vessel atherosclerosis in a real-world clinical setting.
2. Methods
2.1. Patient selection
The symptomatic cohort comprised of 208 consecutive symptomatic patients referred
by their primary care physicians to two outpatient cardiology practices (Toronto and New
York) for evaluation of exercise intolerance (chest pain and shortness of breath) between
December 1, 2013 and August 31, 2015. Exclusion criteria included a prior history of heart
or lung disease. Exclusion criteria after CPET included: 1) insufﬁcient effort (peak respiratory
exchange ratio (RER) ≤ 1.05, unless there was a plateau in O2-pulse after the ventilatory an-
aerobic threshold (VAT) as an indicator of LV dysfunction) and 2) systolic blood pressure at
peak exercise N220mmHg. All patients with a plateau in the O2-pulse (VO2/HR) orwith vi-
sual evidence of acceleration of HR response as a function of work-rate or VO2 were consid-
ered abnormal and referred for invasive coronary angiogram [18]. Symptomatic patients
with normal CPET responses were referred for coronary CT angiogram to assess coronary
anatomy. Informed consent was obtained from all subjects prior to each study.
A healthy cohort was developed to establish a normal HR response pattern. TheMET-
TEST database (n= 136.392) was queried for asymptomatic individuals with no CV risk
factors, BMI b 30, and not on any cardiovascular medications. The normal cohort was test-
ed during the same time as the recruitment period of symptomatic patientswith the same
protocol andwere selected from 24 centers throughout the US. The reason for testing was
annual physical ﬁtness evaluation and/or peak aerobic performance evaluation (commer-
cial pilots,ﬁre-ﬁghters,military, police and recreational athletes). Subjects had to put forth
good effort (peak RER ≥ 1.05)with normal peak VO2 (85–130% of predicted), normal peak
HR (85–110% of age predictedmaximum) and without ECG changes (no ST depression or
arrhythmias) to be included for HR analysis. A total of 116 subjects qualiﬁed for inclusion
with a near equal number of men and women.
2.2. Cardiopulmonary exercise testing (CPET)
Symptom-limited CPET was performed on an electromagnetically-braked cycle er-
gometer using a customized linear-ramp protocol designed to elicit fatigue within 8 to
12 min of exercise. Details of the protocol and equipment have been described earlier
[18]. The ventilatory anaerobic threshold (VAT) was determined using the V-slope meth-
od [22]. Breath-by-breath measured parameters and predicted equations were collected
and interpreted as described by Wasserman et al.. [23]. Numerical results were reported
as a 10 second average and graphical results were displayed using a 20 second average.
Medications were not withheld in the symptomatic cohort prior to testing as the purpose
of the CPET was to determine the mechanism of exercise impairment. All systems were
owned and operated by MET-TEST with centralized calibration and equipment perfor-
mance monitoring from the data center. All technicians were trained and monitored byMET-TEST and each technician acted as a biological control for their system. Data from
all sites was analyzed and maintained in a central database.
Subjects without atherosclerotic heart disease and normal LV function tend to main-
tain a linear HR response throughout exercise when a linear work load is imposed. Fig. 1A
depicts a normal response in a healthy subject. Subjectswith physiologically signiﬁcant is-
chemic burdens will develop mechanical dysfunction at some point after the VAT and be-
fore the end of exercise when myocardial oxygen demand exceeds supply. The HR
response steepens from baseline at the start of mechanical dysfunction due to increased
sympathetic discharge under the control of the autonomic nervous system. Fig. 1B depicts
a pathological response in a patientwith three-vessel O-CADwho underwent coronary ar-
tery bypass graft surgery in this study.
A newmathematical model was developed to objectively quantify the compensatory
HR response after the onset ofmechanical dysfunction. The ﬁrst fewminutes of low inten-
sity exercise represent the warm up period and there is a delay in the rise in HR [23]. The
HRwill start to increase after thewarm-up period and establishes a reliable baseline in the
two-minute period before the VAT. The line of best ﬁt was calculated using the least
squares method at two places during exertion. Slope one (S1) represents the slope of
the line of bestﬁt of the 10 secondaverageddata points over the course of the 2min before
the VAT. Slope two (S2) represents the slope of the line of best ﬁt of the 10 second aver-
aged data points for the last 2 min of exercise prior to test termination. The change in
slope is calculated as percent change from baseline and equals the difference in S2 and
S1 divided by S1 and multiplied by 100. This calculation is expressed as the ΔHR-WR
Slope parameter and represents the change in HR slope in late exercise as a function of in-
creasing work-rate (Watts).
Stress ECG was analyzed for ST changes at peak exercise. A normal response was de-
ﬁned as a lack of signiﬁcant ST-segment changes. A positive response was deﬁned as ST-
segment depression of 1 mm or greater (upsloping or ﬂat) in ≥2 leads. Studies were con-
sidered indeterminate if they had signiﬁcant artifact or other abnormalities such as left
bundle branch block or ST-segment change b1 mm. All studies were interpreted by one
investigator not situated with any site.
2.3. Coronary angiograms
Coronary angiograms were performed in two tertiary care centers as part of routine
clinical care within 30 days of CPET. One cardiologist from each center was responsible
for recording all angiogram results into the database and was blinded to the CPET results.
Coronary angiogram results were categorized as “normal” if the epicardial arteries were
completely free of disease; “NO-CAD” if there were one or more arteries with one or
more lesions that resulted in up to 50% stenosis; and as “O-CAD” if lesions were N50% ste-
notic. Each category represents a progressively higher global atherosclerotic disease bur-
den for which diagnostic and outcomes data were available from prior publications with
similar categorizations.
2.4. Statistical analysis
Values are depicted as their mean± SE or n (%). Gender differences in age and body
mass indexwere analyzed using the Student's t-test. Chi-square tests were used to compare
gender differences between risk factors. Differences between the healthy and symptomatic
cohorts for key peak exercise parameterswere analyzed using a one-wayANOVA and statis-
tically signiﬁcant differenceswere subject to post-hoc analysis using the Bonferroni post-hoc
test. The receiver operator characteristic (ROC) curvewas used to identify the optimal cut-off
point for ΔHR-WR Slope to identify cardiac dysfunction in patients with documented NO-
CAD,O-CADand revascularization. The optimal values for sensitivity and speciﬁcitywerede-
termined by choosing the threshold closest to the upper left corner of the ROC curve. These
values were compared to the diagnostic accuracy of stress ECG. A conﬁdence interval of 95%
was used and p values b 0.05 were considered statistically signiﬁcant. Data was analyzed
using SPSS© version 22. ROC analysis was performed using the life science module of
XLSTAT version 2015.4.01.20116 (www.xlstat.com).
3. Results
All studies (CPET, CT angiograms and invasive coronary angiograms)
were performed without complications. Baseline characteristics of the
study population are shown in Table 1. The distribution of coronary an-
giogram results is shown in Fig. 2. The prevalence of NO-CADandO-CAD
in the symptomatic cohort was 32% and 50% respectively with 26% of
the patients undergoing revascularization. Men had the lowest inci-
dence of normal coronaries and the highest incidence of O-CAD while
women had near equal distribution of normal coronaries, NO-CAD and
O-CAD. Women were ~3 times more likely to have normal coronaries
compared tomen andmenwere ~2 timesmore likely to undergo revas-
cularization compared to women in this study.
The key peak exercise parameters for men and women are listed in
Table 2. While men demonstrated an incremental linear decline
in mean peak VO2 and peak O2-pulse values with progression of
atherosclerotic-burden, symptomatic women with normal coronaries
Fig. 1.Normal and abnormal heart-rate responses. S1= slope of line of best ﬁt for heart-rate response in 2min prior to the ventilatory anaerobic threshold. S2= slope of line of best ﬁt for
heart-rate response in 2 min prior to end of exercise. VAT = Ventilatory Anaerobic Threshold.
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sion observed in the NO-CAD, O-CAD and revascularization groups (Fig.
3). The mean ΔHR-WR Slope values in each category are shown in Fig.
4. This parameter has a slight negative value in the healthy cohort and
progressively increases with increasing atherosclerotic burden in both
men and women. Post-hoc analysis for men revealed that the mean
value of the healthy cohort was signiﬁcantly different from the symp-
tomatic normal coronary (p = 0.006), NO-CAD (p b 0.001), O-CAD
(p b 0.001) and revascularization groups (p b 0.001). Post-hoc analysis
for women revealed that the mean value of the healthy cohort was not
signiﬁcantly different from the symptomatic normal coronary group
(p= 1.0) but was for the NO-CAD (p= 0.001), O-CAD (p b 0.001) and
revascularization groups (p b 0.001).
ROC Curve Analysis results comparing ΔHR-WR Slope with stress
ECG are listed in Table 3. The listed ΔHR-WR Slope cutoff values repre-
sent the highest area under the ROC curve. Compared to stress ECG in
both men and women, ΔHR-WR Slope demonstrates signiﬁcantlyTable 1
Patient characteristics.
Healthy cohort Symptomatic cohort
p
Value
Men
(n = 57)
Women
(n = 59)
Men
(n = 134)
Women
(n = 74)
Age (yrs) 43 ± 1 47 ± 1 60 ± 1 59 ± 1 0.51
BMI (kg/m2) 28.4 ± 0.4 27.2 ± 0.7 28.5 ± 0.4 28.4 ± 0.9 0.89
Smoker n/a n/a 23 12 0.86
Diabetes n/a n/a 43 9 b0.05
Hypertension n/a n/a 74 33 0.14
Dyslipidemia n/a n/a 91 45 0.30
Family history n/a n/a 68 46 0.11
Statin n/a n/a 73 33 0.17
Beta-blocker n/a n/a 28 14 0.73
CCB n/a n/a 8 3 0.55
ACEI n/a n/a 31 14 0.48
ARB n/a n/a 24 9 0.28
ASA n/a n/a 63 31 0.48
Nitrates n/a n/a 4 4 0.39
Diuretic n/a n/a 10 6 0.87
Values are mean ± SE. p Values compare males and females in the symptomatic cohort.
Gender differences in age &BMIwere analyzed using an independent t-test. Gender differ-
ences in risk factors were analyzed using the chi square test. ACEI = angiotensin-
converting enzyme inhibitor; ARB = angiotensin receptor blocker; ASA = aspirin;
CCB = calcium channel blocker.higher sensitivity with little loss in speciﬁcity for detection of athero-
sclerotic burden in the NO-CAD, O-CAD and revascularization groups
in the symptomatic cohort. PPV was slightly better for stress ECG and
NPV was slightly better for ΔHR-WR Slope. As a result of increased sen-
sitivity, the percentage of studies that were reclassiﬁed as abnormal
with ΔHR-WR Slope analysis compared to stress ECG increased from
10% to 55% in the symptomatic normal coronary artery category.
Based on coronary angiogram results, the percentage of studies correct-
ly reclassiﬁed as abnormal compared to stress ECG increased from 22%
to 81% in the NO-CAD category, from 18% to 84% in the O-CAD category
and from 35% to 78% in the revascularization category.
4. Discussion
The current analysis represents the ﬁrst report comparing a normal
HR response in a cohort of healthy individuals with a pathological HR re-
sponse in a cohort of symptomatic individuals with different degrees of
coronary atherosclerotic burden. Because the HR response is under the
control of the autonomic nervous system and is affected by cardiac pa-
thology, it serves as a superior parameter to determine whether the
cause of a patient's symptoms is cardiac in origin or not. This compensa-
tory mechanism provides proof that the net effect of atherosclerotic
heart disease has becomephysiologically signiﬁcant and is impairing car-
diac function during exertion resulting in symptoms. Atherosclerosis has
multiple effects on cardiac structure and function and affects men and
women in different ways. It is possible to have inducible ischemia inde-
pendent of large vessel ﬂow limitation caused by obstructive coronary
artery disease. Mechanisms for IHD include endothelial dysfunction, de-
creased coronary ﬂow reserve (CFR) from increasedmicrocirculatory re-
sistance (arteriolarwall remodelingwith orwithoutmicro-thrombi) and
microvascular spasms [1,11,24–27]. All of these mechanisms have been
shown to increase CV events and worsen prognosis in patients without
O-CAD [28–31]. The initial clinical evaluation of patients without a
prior history of heart disease can be greatly enhanced if a parameter
can accurately identify the net effect of thesemechanisms and guide fur-
ther evaluation. The novel ΔHR-WR Slope parameter presented in the
current study has the potential to ﬁll this role and signiﬁcantly
outperformed stress ECG in this capacity, which is still the current rec-
ommendation for the initial non-invasive evaluation of women at inter-
mediate risk for suspected IHD [16]. Calculation ofΔHR-WR Slope can be
performed by other methods. The process requires a strictly linear work
Fig. 2. Coronary angiogram distribution by sex. NO-CAD= Non-obstructive coronary artery disease (≤50%). O-CAD = Obstructive coronary artery disease (N50%).
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establish a baselineHR slope to compare the HR slope at the end of exer-
cise. CPET has the advantage of using the VAT as a reliable mid-exercise
reference point. The VAT varies in individuals and the calculation re-
quires measurement of both oxygen consumption and carbon dioxide
production during exercise.
4.1. Diagnosis (ΔHR-WR Slope)
To put exercise diagnostic parameters into perspective, theWOMEN
trial documented a 20% stress ECG abnormality rate and a 9% nuclear
myocardial perfusion imaging abnormality rate in women similar to
this study.ΔHR-WR Slope approximately quadrupled the number of ab-
normal studies compared to stress ECG in women with NO-CAD. This
means that ΔHR-WR Slope would increase the number of abnormal
studies approximately 8 fold compared to nuclear myocardial perfusionTable 2
Key peak exercise parameters.
Men
Healthy cohort (n = 57) Symptomatic cohort (n = 177)
Normal coronaries (n = 16)
Mean peak VO2 96.7 ± 0.8% 86.4 ± 5.6%
Mean peak O2-pulse 106 ± 1.2% 94 ± 5.6%
Mean ΔHR-WR Slope −4.6% ± 4% +88 ± 33%
ST changes 0 (0%) 0 (0%)
Women
Healthy cohort (n = 59) Symptomatic cohort (n = 86)
Normal coronaries (n = 24)
Mean peak VO2 98.4 ± 1% 86.7 ± 3.9%
Mean peak O2-pulse 106.6 ± 1.2% 97.1 ± 3.5%
Mean ΔHR-WR Slope −7% ± 5.5% +36 ± 25%
ST changes 0 (0%) 4 (17%)
Values are mean ± SE or n (%). Symptomatic men and women have signiﬁcantly lower peak V
healthy cohorts.
ΔHR-WR Slope= change in heart-rate as a function ofwork-rate slope in the last 2min of exerc
row using a one-way ANOVA.imaging (MPI). Recent data has shown that microvascular dysfunction
in symptomatic patients with NO-CAD is nearly equally prevalent in
men and women (60% and 66% respectively) and correlates poorly
with conventional CV risk factors [11]. Our results reveal that in men,
ΔHR-WR Slope in the revascularization andO-CAD groups is signiﬁcant-
ly different from the healthy cohort (p b 0.001) and not statistically dif-
ferent compared to the NO-CAD and symptomatic normal coronary
groups (p = 0.88 and 0.65 respectively) with 60% of men with NO-
CAD having been demonstrated to have microvascular dysfunction.
Likewise, in women, ΔHR-WR Slope in the revascularization and O-
CAD groups is highly statistically different from the healthy cohort
(p b 0.001) and not statistically different compared to the NO-CAD and
symptomatic normal coronary groups (p=0.55 and 0.057 respectively)
with 66% of women with NO-CAD demonstrated to have microvascular
dysfunction. This data indicates that there is little physiological differ-
ence between NO-CAD and O-CAD in symptomatic patients withp Value
NO-CAD (n = 40) O-CAD (n = 78) Revascularization (n = 43)
76.6 ± 2.1% 70.5 ± 1.6% 68.4 ± 2% b0.05
88.4 ± 2.5% 85.5 ± 1.9% 84.1 ± 2.7% b0.05
+105 ± 13% +102 ± 13% +84 ± 17% b0.05
8 (20%) 21 (27%) 14 (33%) b0.05
p Value
NO-CAD (n = 25) O-CAD (n = 25) Revascularization (n = 12)
85.7 ± 2.5% 86.6 ± 2.3% 85.3 ± 2.2% b0.05
100.8 ± 4% 99.4 ± 2.6% 101.2 ± 2.6% b0.05
+105 ± 28% +130 ± 30% +153 ± 58% b0.05
7 (28%) 8 (32%) 5 (42%) b0.05
O2 and acceleration of HR response in late phase exercise (ΔHR-WR Slope) compared to
ise from baseline. The p value compares statistical signiﬁcance between themeans in each
Fig. 3.Mean peak VO2 (A) and peak (B) O2-pulse values by coronary angiogram class. NO-CAD = Non-obstructive coronary artery disease (≤50%). O-CAD = Obstructive coronary artery disease (N50%).
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Fig. 4.MeanΔHR-WRSlope values by coronary angiogram class.ΔHR-WR Slope=Change inheart-rate as a function ofwork-rate slope in the last 2min of exercise frombaseline= (S2−
S1 ÷ S1) × 100. NO-CAD = Non-obstructive coronary artery disease (≤50%). O-CAD = Obstructive coronary artery disease (N50%).
119S. Chaudhry et al. / International Journal of Cardiology 228 (2017) 114–121differing degrees of large vessel atherosclerotic burden. Both categories
have cardiac dysfunction based on abnormal ΔHR-WR Slope that is
driving symptoms and clinical events. Whether inducible ischemia is a
common denominator in patients with O-CAD and NO-CADwith cardi-
ac dysfunction on CPET requires further investigation. Symptomatic pa-
tients with cardiac dysfunction and NO-CAD are still in need of a
deﬁnitive diagnosis. The next step would be to assess coronary endo-
thelial function and measure coronary ﬂow reserve. These assessments
can be performed invasively during coronary angiogram with acetyl-
choline and adenosine challenges [25]. Non-invasive measurement ofTable 3
ROC analysis comparing ΔHR-WR Slope with stress ECG.
Men
NO-CAD (n = 40) O-CAD (n = 78)
Stress ECG ΔHR-WR Slope
Cutoff = 17%
Stress ECG
AUC 60% 94% 64%
Sensitivity 20% (95% CI, 10–35%) 95% (95% CI, 82–99%) 27% (95% CI, 18–38%
Speciﬁcity 100% (95% CI, 92–100%) 79% (95% CI, 67–88%) 100% (95% CI, 92–10
PPV 100% 76% 100%
NPV 64% 96% 50%
Accuracy 67% 86% 58%
Women
NO-CAD (n = 25) O-CAD (n = 25)
Stress ECG ΔHR-WR Slope
cutoff = 68%
Stress ECG
AUC 64% 85% 66%
Sensitivity 28% (95% CI, 14–48%) 68% (95% CI, 48–83%) 32% (95% CI, 17–52%)
Speciﬁcity 100% (95% CI, 92–100%) 95% (95% CI, 85–99%) 100% (95% CI, 93–100
PPV 100% 85% 100%
NPV 77% 88% 78%
Accuracy 79% 87% 80%
ΔHR-WR Slope demonstrates signiﬁcantly higher sensitivity for detection of under-treated ath
diagnostic accuracy. PPV is higher for stress ECG and NPV is higher for ΔHR-WR Slope.
ΔHR-WR Slope = change in heart-rate as a function of work-rate slope in the last 2 min of exe
NO-CAD = non-obstructive coronary artery disease (≤50%).
O-CAD = obstructive coronary artery disease (N50%).
AUC = area under receiver operating curve (ROC).
PPV = positive predictive value. NPV = negative predictive value.coronary ﬂow reserve can be performed by ultrasound techniques [13,
30], cardiac positron emission tomography (Cardiac PET) [32] and car-
diac MRI [33].
Non-atherosclerotic causes of cardiac dysfunction should also be
considered. Othermechanisms that can causemyocardial energy deple-
tion during exertion include congenital disorders (hypertrophic cardio-
myopathy, anomalous coronary anatomy, myocardial bridging, and
mitochondrial cardiomyopathy), valve disease (severe aortic stenosis
and mitral regurgitation) and hypertensive systolic blood pressure re-
sponse (SBP ≥ 220 mm Hg).Revascularization (n = 43)
ΔHR-WR Slope cutoff
=14%
Stress ECG ΔHR-WR Slope
cutoff = 14%
80% 66% 83%
) 86% (95% CI, 76–92%) 33% (95% CI, 21–48%) 79% (95% CI, 65–89%)
0%) 79% (95% CI, 67–88%) 100% (95% CI, 92–100%) 79% (95% CI, 67–88%)
85% 100% 74%
80% 66% 83%
83% 71% 79%
Revascularization (n = 12)
ΔHR-WR Slope
cutoff = 70%
Stress ECG ΔHR-WR Slope
cutoff = 81%
90% 71% 89%
76% (95% CI, 56–89%) 42% (95% CI, 19–68%) 75% (95% CI, 46–92%)
%) 97% (95% CI, 88–100%) 100% (95% CI, 93–100%) 98% (95% CI, 90–100%)
90% 100% 90%
90% 89% 95%
90% 90% 94%
erosclerotic burden compared to stress ECG with similar speciﬁcity resulting in improved
rcise from baseline.
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Aside from providing diagnostic value by assessing for cardiac dys-
function, CPET is the gold standard for quantifying cardiorespiratory ﬁt-
ness (CRF) for prognostic purposes because it directly measures peak
VO2 as opposed to estimating exercise capacity. Of all exercise and im-
aging based parameters, CRF (peak VO2) has proven to be the#1 predic-
tor of all-cause mortality in men and women without known CAD as
well as mortality in patients with known CAD [34–37]. Direct measure-
ment of peak VO2 enables more precise risk stratiﬁcation at baseline as
well as the ability to track changes in clinical status with serial testing.
The male patients in this study exhibited a linear incremental decline
in peak VO2 with increasing atherosclerotic burden indicating progres-
sively worsening prognosis with the lowest mean peak VO2 = 68% of
age-predicted in the revascularization group. Symptomatic women re-
veal a clear decline compared to the healthy cohort but little change
with progression of atherosclerotic burden with relatively well pre-
served functional capacity of 85% of age-predicted in the revasculariza-
tion group. This may be a reﬂection of the lesser degree of large vessel
atherosclerosis seen in women compared to men. The ﬁnding of pre-
served functional capacity in symptomatic women with suspected is-
chemic heart disease is consistent with prior reports [38]. The goal of
any type of therapeutic intervention in patients with IHD is to improve
quality of life and survival and direct measurement of peak VO2 after
cardiac rehabilitation predicts long-term prognosis [39]. Exercise has a
protective effect independent of traditional risk factors [40]. Quantifying
Peak VO2 assesses all beneﬁcial aspects as well as monitoring compli-
ance. Because exercise and medical therapy are the cornerstones of
treatment for patients with NO-CAD, serial peak VO2 comparison en-
ables a higher degree of precision for clinical tracking on an individual
basis.
4.3. Limitations
This study is a comparison between a younger asymptomatic,
presumed healthy cohort and a relatively older symptomatic cohort.
By its very nature, the presence of heart disease is going to lower
peak VO2 and thus result in a difference in ﬁtness levels between
the two groups. Having age and sexmatched asymptomatic, relative-
ly sedentary individuals without cardiovascular risk factors would
have made for a more ideal healthy cohort but was not feasible in
this clinical observational study. It was also assumed that all patients
in the healthy cohort had no IHD and the presence of subclinical IHD
may explain increased ΔHR-WR Slope values in some subjects.
Heart-rate limiting medications were not withheld prior to CPET.
Blunting of HR response will skew each study towards a normal re-
sponse. Men had a higher rate of diabetes than women in our popu-
lation and this may be a contributing factor for the higher degree of
large vessel atherosclerosis and lower observed peak VO2. As with
most diagnostic studies, the presence of work-up bias must be con-
sidered since many subjects had diagnostic procedures as a result
of their exercise test results. Since this study required clinical judge-
ment in real-world situations, work-up bias was unavoidable. Frac-
tional ﬂow reserve (FFR) was not measured as this procedure is not
routinely performed at the participating hospitals. This study did
not track long-term effects on cardiovascular end points or down-
stream resource utilization. Future studies should correct for these
limitations.
4.4. Future research
Because there was no signiﬁcant difference in the ΔHR-WR Slope pa-
rameter between the symptomatic normal coronary, NO-CAD andO-CAD
groups in both sexes with symptoms, it is possible that microvascular
dysfunction is the common link between the three groups. Individuals
with greater large vessel atherosclerosis burden are also likely to havemicrovascular disease. Future research should assess detailed coronary
physiological function in all three groups and peak VO2 should be closely
monitored to correlate with long-term CV events.
5. Conclusion
This study demonstrates that cardiopulmonary exercise testing is
more effective than traditional stress ECG for the detection of obstruc-
tive and non-obstructive coronary artery disease when used in the ini-
tial evaluation of patients suspected of having IHD. The novel ΔHR-
WR Slope parameter signiﬁcantly increased the sensitivity to detect
under-treated atherosclerosis veriﬁed by coronary angiogramwith little
loss in speciﬁcity. CPET is particularly suited as the ﬁrst line tool for the
assessment of symptoms inwomen because of low cost, safety (no radi-
ation), superior sensitivity and widespread availability in most hospi-
tals. An abnormal study conﬁrms that common atypical symptoms are
cardiac in origin and further evaluation is warranted.
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